Skip to content

Effectiveness of repeated transcranial magnetic stimulation on sleep quality, emotional disturbance and severity of disorder symptoms in patients with emotional disorders

Effectiveness of repeated transcranial magnetic stimulation on sleep quality, emotional disturbance and severity of disorder symptoms in patients with emotional disorders

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240713062416N1
Enrollment
60
Registered
2024-07-18
Start date
2024-07-24
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavioral and emotional disorders. Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence

Interventions

Intervention 1: Intervention group: This research will be conducted on patients with emotional disorders and the intervention will include 20 sessions (regularly on 5 days of the week). The experiment

Sponsors

Islamic Azad University Semnan branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients must be certified by a psychiatrist or psychologist based on DSM-5 or ICD-10 diagnostic criteria. The age range of participants should be between 18 and 65 years. Patients must have moderate to severe symptom severity as assessed using validated instruments such as the Beck Depression Scale (BDI), Hamilton Anxiety Scale (HAM-A), or similar instruments. Patients must sign informed consent and be willing to participate in all repeated transcranial magnetic stimulation sessions and related assessments. Patients who are currently receiving medication or psychotherapy should have stable treatment and not have any major changes in their treatment for at least 4 weeks before the start of the study. Patients must have significant problems in sleep quality and emotional disturbances that affect their quality of life and daily performance.

Exclusion criteria

Exclusion criteria: Patients diagnosed with other psychiatric disorders such as psychotic disorders, bipolar disorders or substance abuse disorders in the period of 6 months before the start of the study. Taking medications that may interfere with transcranial magnetic stimulation, such as anticonvulsants or antipsychotics. Patients with serious physical problems such as cardiovascular disease, renal or hepatic failure, or serious neurological disease that may interfere with the treatment protocol. Patients with metal implants in the head or neck area (such as implanted hearing aids) that may be stimulated by magnetic fields. Pregnant or lactating women due to unknown risks to the fetus or infant. Patients who do not attend or follow instructions for repeated transcranial magnetic stimulation sessions or follow-up assessments. Patients who decide to withdraw from the study at any stage of the research and do not want to continue.

Design outcomes

Primary

MeasureTime frame
Sleep quality. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Pittsburgh Sleep Quality Questionnaire (PSQI).;Emotional disturbance. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Emotional disturbance questionnaire (DASS21).;Severity of disorder symptoms. Timepoint: Before intervention and after 20 intervention sessions. Method of measurement: Clinical General Impression Questionnaire (CGI).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Sohrabi

Islamic Azad University Semnan branch

fsohrabi.master@gmail.com+98 21 3364 5489

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026